Ignite Creation Date:
2025-12-24 @ 11:47 PM
Ignite Modification Date:
2026-04-06 @ 7:33 AM
Study NCT ID:
NCT00103051
Status:
COMPLETED
Last Update Posted:
2012-07-16
First Post:
2005-02-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Gemcitabine, Cisplatin, and Gefitinib in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer
Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
EORTC-08013
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None